ArticleThe Journal of cell biology1990

Tumor necrosis factor and CD11/CD18 (beta 2) integrins act synergistically to lower cAMP in human neutrophils.

C Nathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.